0.575 (0.0%)

T-O: 0.575 (08:59:00)
Last updated: 17:00

Fundamental   4.4  
Technical   2.9  
Total Score   7.3  



iSaham Fundamental Trend

FCON: 0.66 | Sharpe Ratio: -0.1 | LTS: 6.36

Quarter Reports

Trailing Dividend

Financial Ratios

EPS 1.17 sen
Trailing PE (Sector Median: 31.6) 49.3
PEG 0.57
Altman Z 0.6
Beaver 0.083
Current Ratio 2.46
Debt-Equity (DE) Ratio 0.34
FCF Yield -8.12 %
Revenue QoQ 253.33 %
Revenue YoY 31.04 %
Profit QoQ 34.04 %
Profit YoY 52.57 %
All-Time Profit Margin (Sector Median: 5.4) 12.9 %
ROE (ROIC: 2.12) 2.57 %
Dividend Per Share (DPS) 0.22 sen
Dividend Yield (DY) 0.38 %

Fair Value

Weighted Average Fair Value: 0.37

Discounted Cash Flow (DCF) 5% Growth 0.11
Discounted Cash Flow (DCF) 10% Growth 0.15
Relative Valuation 0.37
Graham Formula 0.085
Graham Number 0.335
Net Tangible Asset (NTA) 0.45
Consistent QR FV N/APremium Access Only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit 3.75
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 319.15
Expected Revenue (M) 2690.98
Expected Growth (%) 43.0

Directors Share Purchases (Beta)

No transaction in the last 2 months.



Market Cap: 998 M.

Number of Shares: 1736 M.

Adjusted Float: 22.2%.

Stock highly correlated with

EG (90%)


SCABLE (90%)


Manipulation Indicator: Very hard to manipulate.

TMC Life Sciences Berhad, through its subsidiaries, provides a range of fertility treatment services in Malaysia. It is engaged in the development, marketing, management of healthcare programs; provision of storage of cord blood and adult stem cells, stem cell therapy, and application services. It operates women's clinic and medical center; and provides gynecological and fertility problem management, as well as consultancy, and research and development services. The company operates TMC fertility centers. The company was founded in 1994 and is headquartered in Petaling Jaya, Malaysia.

Sectors: Trading & Services, Healthcare, Medical Service & Equipment, Health Care Providers, Budget 2021

Code: 0101


Related Links: Bursa | Annual Report | Announcement

Top Shareholdings

Updated on 1-Sep-2021

Shareholder Value (M)
Sasteria (M) Pte. Ltd. 702.41
DYAM Tunku Ismail Ibni Sultan Ibrahim 76.52
Credit Suisse 48.08
Siow Wong Yen @ Siow Kwang Hwa 26.34
UOB Kay Hian Pte. Ltd. 18.73
CGS-CIMB Securities (Singapore) Pte. Ltd. 9.52
Lembaga Tabung Amanah Warisan Negeri Terengganu 8.21
Credit Suisse AG 7.11
Lim Gaik Bway @ Lim Chiew Ah 2.7
Surinder Singh A/L Ranbir Singh 2.6
Ho Lih Meng 2.4
Wong Fuei Boon 2.3
Wong Wai Kong 2.0
Lim Zhong Yong 1.4
Chiew Poh Cheng 1.3
Ng Aik Sern 1.2
Koh Chun Cheuk 0.9
Mohd Salleh Bin Hj Harun 0.9
Hooi Thien Eng 0.8
Yew Boon Hean 0.8
Tan Li Lian 0.8
Chiew Lik Ing 0.8
Chai Kok Kum 0.7
Su Ming Yaw 0.7
Chow Hung Khim 0.7